Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a Trial.

Saved in:
Bibliographic Details
Title: Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a Trial.
Authors: Iroh Tam P; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Arnold SLM; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA., Barrett LK; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA., Chen CR; Emmes, Rockville, Maryland, USA., Conrad TM; Emmes, Rockville, Maryland, USA., Douglas E; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA., Gordon MA; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom., Hebert D; Emmes, Rockville, Maryland, USA., Henrion M; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Hermann D; Bill & Melinda Gates Foundation, Seattle, Washington, USA., Hollingsworth B; Emmes, Rockville, Maryland, USA., Houpt E; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA., Jere KC; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi.; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom., Lindblad R; Emmes, Rockville, Maryland, USA., Love MS; Calibr, La Jolla, California, USA., Makhaza L; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., McNamara CW; Calibr, La Jolla, California, USA., Nedi W; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Nyirenda J; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Operario DJ; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA., Phulusa J; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Quinnan GV; Emmes, Rockville, Maryland, USA., Sawyer LA; Emmes, Rockville, Maryland, USA., Thole H; Paediatrics and Child Health Research Group, Malawi-Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Toto N; Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Winter A; Emmes, Rockville, Maryland, USA., Van Voorhis WC; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 15; Vol. 73 (2), pp. 183-191.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-6591
DOI:10.1093/cid/ciaa421